Received approval from the FDA. Fantastic news for the company.
anonymous Guest anonymous Mar 11, 2023 at 07:59: AM #1 anonymous Guest Received approval from the FDA. Fantastic news for the company.
anonymous Guest anonymous Mar 13, 2023 at 04:34: PM #2 anonymous Guest and the stock price drops. All stock options underwater. SMH
anonymous Guest anonymous Mar 14, 2023 at 12:54: AM #3 anonymous Guest Lots of stocks down because of the Silicon Valley bank collapse Give Acadia 12 months The question is tolerability for the Rhett product. if we can manage it. I see 1 billion in sales a year from now and stock price of $70
Lots of stocks down because of the Silicon Valley bank collapse Give Acadia 12 months The question is tolerability for the Rhett product. if we can manage it. I see 1 billion in sales a year from now and stock price of $70
anonymous Guest anonymous Mar 14, 2023 at 11:13: AM #4 anonymous Guest anonymous said: Lots of stocks down because of the Silicon Valley bank collapse Give Acadia 12 months The question is tolerability for the Rhett product. if we can manage it. I see 1 billion in sales a year from now and stock price of $70 Click to expand... 100 patients a month at the price we are charging would get us there. Might want to think about broadening access beyond Anovo Specialty if we expect that to happen.
anonymous said: Lots of stocks down because of the Silicon Valley bank collapse Give Acadia 12 months The question is tolerability for the Rhett product. if we can manage it. I see 1 billion in sales a year from now and stock price of $70 Click to expand... 100 patients a month at the price we are charging would get us there. Might want to think about broadening access beyond Anovo Specialty if we expect that to happen.
